. - Revenues from hotel operations in Q1/2019 amounted 88.15 million baht increased by 9.18 million baht or 11.62% from 78.97 million baht in Q1/2018 due to the opening of new hotel, MAVEN Stylish Hotel Bangkok
. - Revenues from hotel operations in Q2/2019 amounted 71.35 million baht increased by 8.98 million baht or 14.40% from 62.37 million baht in Q2/2018 due to the opening of new hotel, MAVEN Stylish Hotel Bangkok
baht in 2018 due to the opening of new hotel, MAVEN Stylish Hotel Bangkok. - Management fee income in 2019 amounted 87.93 million baht increased by 28.42 million baht or 47.76% from 59.51 million baht in
Discussion and Analysis for the period 3 months September 30, 2017. as follows:- Million Baht By Consolidation method The Company Q3/2017 Q3/2016 Q3 Different Q3/2017 Q3/2016 Q3 Different Sales and service
Analysis for Year Ended December 31, 2017 as follows:- Consolidation Financial Statement (MB) The Company (MB) 2017 2016 Different 2017 2016 Different Sales and Service Income 4,731 3,713 1,018 27% 4,190
Analysis for the period 3 months March 31, 2018 as follows:- (Million Baht) Consolidation Financial Statement The Company Q1/2018 Q1/2017 Different Q1/2018 Q1/2017 Different Sales and service income 1,046.66
Analysis for the period 3 months June 30, 2017 as follows:- Million Baht By Consolidation method The Company Q2/17 Q2/16 Q2/Different Q2/17 Q2/16 Q2/Different Sales and service income 1,037 856 181 21% 907
December 2019, compared to the same period of the previous year as follows Company performance For the period ended December 31, 2019 Million Baht Consolidation method The Company 2019 2018 Different 2019
profit at 3 million. By order of the operating results for the 1st quarter of 2019 and year 2018 are summarized below. Million Baht Consolidation method The Company Q1/2019 Q1/2018 Different Q1/2019 Q1
profit at 38 million. By order of the operating results for the Second quarter of 2019 and year 2018 are summarized below. Million Baht Consolidation method The Company Q2/2019 Q2/2018 Different Q2/2019 Q2